SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

RAMSAY DAVID A

(Last)

(First)

(Middle)

11388 SORRENTO VALLEY ROAD

(Street)

SAN DIEGO

92121

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/20/2013

3. Issuer Name and Ticker or Trading Symbol
HALOZYME THERAPEUTICS INC [ HALO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP and Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	105,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option to Purchase Common Stock	11/11/2007	11/11/2013	Common Stock	130,000	$0.39	D
Option to Purchase Common Stock	12/08/2008	12/08/2014	Common Stock	20,058	$2.02	D
Option to Purchase Common Stock	02/01/2009	10/13/2014	Common Stock	50,000	$2.05	D
Option to Purchase Common Stock	⁽¹⁾	02/04/2020	Common Stock	14,697	$5.55	D
Option to Purchase Common Stock	02/06/2012	02/06/2018	Common Stock	24,620	$5.6	D
Option to Purchase Common Stock	02/05/2013	02/05/2019	Common Stock	25,148	$6.1	D
Option to Purchase Common Stock	02/04/2014⁽²⁾	02/04/2023	Common Stock	17,700	$6.55	D
Option to Purchase Common Stock	⁽³⁾	02/03/2021	Common Stock	15,022	$7.14	D
Option to Purchase Common Stock	02/05/2011	02/05/2017	Common Stock	12,943	$7.51	D
Option to Purchase Common Stock	02/02/2013⁽²⁾	02/02/2022	Common Stock	25,000	$11.29	D
Restricted Stock Award	⁽⁴⁾	02/02/2022	Common Stock	9,375	$0	D
Restricted Stock Award	02/04/2014⁽⁵⁾	02/04/2024	Common Stock	8,850	$0	D

Explanation of Responses:

1. 4,220 shares of this option grant vest in equal monthly installments of 469 shares. The remaining balance is fully vested.

2. This option vests one-fourth on such date and then 1/48 monthly thereafter.

3. 8,205 shares of this option vest in equal monthly increments of 391 shares. The remaining balance is fully vested.

4. This restricted stock award vests in equal annual installments of 3,125 shares in February of 2014, 2015 and 2016.

5. This award vests one-fourth on such date and then one-fourth on each anniversary thereafter.

	David A. Ramsay	05/24/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.